Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 5, 1999, Pages 729-735

  Pollard, K Michael ^a,c   Pearson, Deborah L ^a   Hultman, Per ^b   Hildebrandt, Bernhard ^a   Kono, Dwight H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

^c SBR6 ^*  (United States)

Author keywords

Animal model; Autoimmunity; Lupus; Mercury; Nickel; Xenobiotic

Indexed keywords

AUTOANTIBODY; MERCURY; NICKEL; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HYPERGAMMAGLOBULINEMIA; IMMUNE COMPLEX DEPOSITION; IMMUNOPATHOLOGY; IMMUNOTOXICITY; LYMPHOID HYPERPLASIA; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; XENOBIOTIC METABOLISM;

ANIMALIA; MURINAE;

EID: 0032700928     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s5729     Document Type: Article

References (41)

1. Rubin RL. Drug-induced lupus. In: Dubois' Lupus Erythematosus, 5th ed (Wallace DJ, Hahn BH, eds). Baltimore, MD:Williams and Wilkins, 1997:871-901.
2. Silver RM. Scleroderma and pseudoscleroderma. In: Systemic Sclerosis (Clements PJ, Furst DE, eds). Baltimore, MD:Williams and Wilkins, 1996:81-98.
3. Kono DH, Theofilopoulos AN. Genetic contributions to SLE. J Autoimmunity 9:437-452 (1936).
4. Hang L, Slack JH, Amundson C, Izui S, Theofilopoulos AN, Dixon FJ. Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med 157:874-883 (1983).
5. Ansel JC, Mountz J, Steinberg AD, DeFabo E, Green I. Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB male mice. J Invest Dermatol 85:181-186 (1985).
6. Lewis RE, Cruse JM, Johnson WW, Mohammad A. Histopathology and cell-mediated immune reactivity in halothane-associated lymphomagenesis and autoimmunity in BXSB/Mp and MRL/Mp mice. Exp Mol Pathol 36:378-395 (1982).
7. Carpenter DF, Steinberg AD, Schur PH, Talal N. The pathogenesis of autoimmunity in New Zealand mice. II: Acceleration of glomerulonephritis by polyinosinic.polycytidylic acid. Lab Invest 23:628-634 (1970).
8. Theofilopoulos AN. Murine models of lupus. In: Systemic Lupus Erythematosus. 2nd ed (Lahita RG, ed). NewYork:Churchill Livingstone, 1992:121-194.
9. Theofilopoulos AN, Kono DH. Murine Lupus Models: Gene-specific and genome-wide studies. In: Systemic Lupus Erythematosus, 3rd ed (Lahita RG, ed). New York Churchill Livingstone, 1999:149-181.
10. Pollard KM, Hultman P. Effects of mercury on the immune system. In: Metal Ions in Biological Systems. Vol 34: Mercury and Its Effects on Environment and Biology (Sigel H, Sigel A, eds). Basel:Marcel Dekker, 1997:421-440.
11. Bigazzi PE. Animal models of autoimmunity: spontaneous and induced. In: The Autoimmune Diseases (Rose NR, Mackay IR, eds). New York:Academic Press, 1998:211-244.
12. Barr RD. The mercurial nephrotic syndrome. E Afr Med J 67:381-386 (1990)
13. Ochel M, Vohr HW, Pfeiffer C, Gleichmann E. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 146:3006-3011 (1991).
14. Kono, DH, Balomenos D, Pearson DL, Park MS, Hildebrandt B, Hultman P, Pollard KM. The prototypic autoimmunity induced by mercury is dependent on IFN-γ and not Th1/Th2 imbalance. J Immunol 161:234-240 (1998).
15. Tian L, Lawrence DA. Metal-induced modulation of nitric oxide production in vitro by murine macrophages: lead, nickel, and cobalt utilize different mechanisms. Toxicol Appl Pharmacol 141:540-547 (1996).
16. Goebeler M, Roth J, Bröcker E-B, Sorg C, Schultze-Osthoff K. Activation of nuclear factor-κB and gene expression in human endothelial cells by the common haptens nickel and cobalt. J Immunol 155:2459-2467 (1995).
17. Bernstein DI. Allergic reactions to workplace allergens. JAMA 278:1907-1913 (1997).
18. Van Hoogstraten IM, Boos C, Boden D, Von Blomberg ME, Scleper RJ, Kraal G. Oral induction of tolerance to nickel sensitization in mice. J Invest Dermatol 101:26-31 (1993).
19. + T cells. Immunol Today 12:392-395 (1991).
20. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC:National Academy Press, 1996.
21. Kono D, Burlingame R, Owens DG, Kuramochi A, Balderas RS, Balomenos, D, Theofilopoulos AN. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 91:10168-10172 (1994).
22. Takeuchi K, Turley SJ, Tan EM, Pollard KM. Analysis of trie autoantibody response to fibrillarin in human disease and murine models of autoimmunity J. Immunol 154:691-971 (1995).
23. 1 mouse and some human scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP particle. Arthritis Rheum 30:793-800 (1987).
24. Burlingame RW, Rubin RL. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Meth 143:187-199 (1990).
25. Kotzin BL, Lafferty JA, Portanova JP, Rubin RL, Tan EM. Monoclonal anti-histone autoantibodies derived from murine models of lupus. J Immunol 133:2554-2559 (1984).
26. Bell S, Hobbs M, Rubin R. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J Immunol 148:3369-3376 (1992).
27. Hultman P, Turley SJ, Eneström S, Lindh U, Pollard KM. Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J Autoimmunity 9:139-149 (1996).
28. Burlingame RW, Rubin RL, Balderas RS, Theofiopoulos AN. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91:1687-1695 (1993).
29. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role ol chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94:184-192 (1994).
30. Rubin RL, Bell SA, Burlingame RW. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest 90(1):165-173 (1992).
31. Hultman P, Bell LJ, Eneström S, Pollard KM. Murine susceptibility to mercury. 1: Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol 65:98-108 (1992).
32. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J Exp Med 148:1198-1215 (1987).
33. Rodgers KE. Effects of oral administration of malathion on the course of disease in MRL-lpr mice. J Autoimmunity 10:367-373 (1997).
34. Kahn MF, Kaphalia BS, Ansari GA. Time-dependent autoimmune response of dichloroacetyl chloride in female MRI+/+ mice. Immunopharmacol Immunotoxicol 19:265-277 (1997).
35. Theofilopoulos AN, Dixon FJ. Experimental murine systemic lupus erythematosus. In: Systemic Lupus Erythematosus (Lahita RG. ed). New York:John Wiley and Sons, 1987:121-202.
36. d congenic mice. Clin Immunol Immunopathol 68:9-20 (1993).
37. Griem P, Wulferink M, Sachs B, González JB, Gleichmann E. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19:133-141 (1998).
38. Druet P, Pelletier L. Th2 and Th1 autoreactive anti-class II cell lines in the rat suppress or induce autoimmunity. J Autoimmunity 9:221-226 (1996).
39. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature [Letter]. Cell 87:171 (1996).
40. Pollard KM, Pearson DL, Hultman P, Hildebrandt B, Kono DH. Unpublished data.
41. Fritzler MJ, Rubin RL. Drug-induced lupus. In: Dubois Lupus Erythematosus. 4th ed (Wallace DJ, Hahn BH, eds). London:Lea and Febiger, 1993:442-453.